Clinical trial
A Randomized, Controlled Trial of Continuous Heparin Versus Placebo Infusion to Prevent Catheter-related Thrombosis in Infants After Cardiac Surgery
NCT04767113 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Trial of Continuous Heparin Versus Placebo Infusion to Prevent Catheter-related Thrombosis in Infants After Cardiac Surgery
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- August 31, 2022
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery, central venous catheter thrombosis, heparin